Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding (Q37149381)

18 August 2017

Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding (English)

1 reference

18 August 2017

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Harish Raja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Eric L Matteson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Clement J Michet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Jose S Pulido

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

publication date

21 September 2012

1 reference

Translational vision science & technology

18 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

Patterns of medication use during pregnancy in rheumatoid arthritis

14 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Golimumab for rheumatoid arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Is infliximab safe to use while breastfeeding?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

TNF-alpha protects embryos exposed to developmental toxicants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Certolizumab use in pregnancy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

A successful pregnancy in a patient with Takayasu's arteritis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Adalimumab use in pregnancy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763882

Pregnancy during adalimumab use for psoriasis

4 December 2018

1 reference

12 December 2020

Successful use of adalimumab (Humira) for Crohn's disease in pregnancy

1 reference

12 December 2020

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

1 reference

12 December 2020

Successful use of infliximab for perianal Crohnʼs disease in pregnancy

1 reference

12 December 2020

Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate

1 reference

12 December 2020

Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease

1 reference

12 December 2020

Inadvertent conception during concomitant treatment with infliximab and methotrexate in a patient with Crohn's disease: is the game worth the candle?

1 reference

12 December 2020

Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature

1 reference

12 December 2020

Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum

1 reference

12 December 2020

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

1 reference

12 December 2020

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship

1 reference

12 December 2020

A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment

1 reference

12 December 2020

Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

1 reference

12 December 2020

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy

1 reference

12 December 2020

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

1 reference

12 December 2020

Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis

1 reference

12 December 2020

Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)

1 reference

12 December 2020

Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis

1 reference

12 December 2020

Measuring multiple etanercept levels in the breast milk of a nursing mother with rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept)

1 reference

12 December 2020

Infliximab treatment and pregnancy outcome in active Crohn's disease

1 reference

12 December 2020

Identifiers

DOI

10.1167/TVST.1.2.6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24049706%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

1 reference